AbbVie Inc (NYSE: ABBV)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $207.94
-
Support level$204.61
-
Resistance level$232.90
-
Beta0.4
-
RSI (14-day)53.8
- ABBV is one of this month's worst performers with a return of -7.7 percent, underperforming 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- ABBV is below its 200-day moving average - additional caution warranted in long positions.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $170.16 | $244.38 | 55.4% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $216.76 | $220.49 | $210.89 | $210.88 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week5.6%
-
In the next month13.5%
-
In the next year52.6%
| Period | Value |
|---|---|
| Historical (5 year) | 23.0% |
| Last month | 21.0% |
| Current estimate | 20.7% |
| Next month forecast | 23.9% |